Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131788) titled 'Clinical Performance Study of Molecular POCT Testing for Respiratory Pathogens' on Sept. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shenzhen Third People's Hospital
Condition:
Respiratory tract pathogen infection
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-01-01
Target Sample Size: Molecular POCT detection group and traditional molecular laboratory qPCR detection observation group:3000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=295093
Published by HT Digital Content Services w...